146 related articles for article (PubMed ID: 2067119)
1. Stage I epithelial ovarian tumors of low malignant potential.
Sawada M; Yamasaki M; Urabe T; Hashimoto K; Katayama S
Jpn J Clin Oncol; 1991 Feb; 21(1):30-4. PubMed ID: 2067119
[TBL] [Abstract][Full Text] [Related]
2. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
3. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
4. Conservative treatment of borderline ovarian tumors.
Tazelaar HD; Bostwick DG; Ballon SC; Hendrickson MR; Kempson RL
Obstet Gynecol; 1985 Sep; 66(3):417-22. PubMed ID: 4022501
[TBL] [Abstract][Full Text] [Related]
5. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
[TBL] [Abstract][Full Text] [Related]
6. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
[TBL] [Abstract][Full Text] [Related]
7. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].
Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S
Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214
[TBL] [Abstract][Full Text] [Related]
8. Ovarian mucinous borderline tumors of intestinal type without intraepithelial carcinoma: are they still tumors of low malignant potential?
Nomura K; Aizawa S; Hano H
Pathol Int; 2004 Jun; 54(6):420-4. PubMed ID: 15144401
[TBL] [Abstract][Full Text] [Related]
9. Ovarian epithelial tumors of low malignant potential: a case series of 5 adolescent patients.
Aggarwal A; Lucco KL; Lacy J; Kives S; Gerstle JT; Allen L
J Pediatr Surg; 2009 Oct; 44(10):2023-7. PubMed ID: 19853767
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases.
Lim-Tan SK; Cajigas HE; Scully RE
Obstet Gynecol; 1988 Nov; 72(5):775-81. PubMed ID: 3173929
[TBL] [Abstract][Full Text] [Related]
11. Pseudomyxoma peritonei: a review of 23 cases.
Wertheim I; Fleischhacker D; McLachlin CM; Rice LW; Berkowitz RS; Goff BA
Obstet Gynecol; 1994 Jul; 84(1):17-21. PubMed ID: 8008316
[TBL] [Abstract][Full Text] [Related]
12. [Ovarian low malignant potential tumor: how to preserve fertility?].
Koskas M; Madelenat P; Yazbeck C
Gynecol Obstet Fertil; 2009; 37(11-12):942-50. PubMed ID: 19819742
[TBL] [Abstract][Full Text] [Related]
13. [Borderline tumors of the ovary: a multicenter study in 137 patients].
Bonnamy L; Fignon A; Fetissof F; Berger C; Body G; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):272-81. PubMed ID: 11398004
[TBL] [Abstract][Full Text] [Related]
14. Epithelial ovarian tumors of borderline malignancy: long-term follow-up.
Casey AC; Bell DA; Lage JM; Fuller AF; Nikrui N; Rice LW
Gynecol Oncol; 1993 Sep; 50(3):316-22. PubMed ID: 8406194
[TBL] [Abstract][Full Text] [Related]
15. [Ovarian serous borderline tumor: the prognostic relation to the pathologic features and management].
Zhou XR; Du XG
Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):601-3, 637. PubMed ID: 7712874
[TBL] [Abstract][Full Text] [Related]
16. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
Cuatrecasas M; Catasus L; Palacios J; Prat J
Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
[TBL] [Abstract][Full Text] [Related]
17. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
[TBL] [Abstract][Full Text] [Related]
18. Recurrence and prognostic factors in borderline ovarian tumors.
Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
[TBL] [Abstract][Full Text] [Related]
19. [The treatment of borderline ovarian tumors and its prognosis].
Li ZX; Qiu XF
Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):207-9, 251-2. PubMed ID: 8082441
[TBL] [Abstract][Full Text] [Related]
20. Surgical staging, treatment, and follow-up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland.
Kumpulainen S; Kuoppala T; Leminen A; Komulainen M; Puistola U; Sankila R; Mäkinen J; Grénman S
Acta Obstet Gynecol Scand; 2007; 86(5):610-4. PubMed ID: 17464592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
